Orchid Pharma Limited — Others, 19-12-2024: Giving guarantees/indemnity/ becoming a surety for third party

Orchid Pharma Limited has announced a board meeting to discuss the corporate guarantee provided for a term loan taken by its wholly owned subsidiary, Orchid Bio-Pharma Limited. This guarantee, amounting to ₹447.22 crore, has been issued in favor of HDFC Bank, ICICI Bank, and YES Bank. The implications indicate potential increased financial leverage and contingent liabilities for Orchid Pharma. By securing this funding, the company aims to bolster its subsidiary’s operational capacity, which may enhance long-term growth prospects. Investors may view this as a positive outlook, reflecting strategic support for subsidiary operations despite the associated risks of contingent liabilities.